Advance Your Practice—AI-Powered Skin Cancer Detection in the Palm of your Hand!
Miss Less Melanoma With Immediate, Non-Invasive Skin Cancer Risk Results
“The beauty of the device is how simple it is… it is simple, easy, and straightforward.”
“The feedback from patients has been excellent…giving them peace of mind about their skin cancer risk.”
“I think this is a revolutionary new product that can help us aid in the management of safety and wellness for our patients. In that, we can highlight and see whether any areas, dark areas, could potentially be cancerous.”
“Integrating DermaSensor’s innovative technology into our practice, we now offer enhanced skin cancer assessment capabilities in our community, ensuring timely referrals for our patients.”
“For me, it was a no-brainer to choose the device…it’s crucial to recognize that skin cancers do not always present the same way in people of color.”
“If you have DermaSensor, in 15 or 30 seconds, you can advise your patient that this is something you are going to refer to a dermatologist, or keep an eye on it, and you can re-evaluate on their next visit.”
“I mean, a lot of my patients are very complex. It’s like an internal medicine practice.
You just had to, you just have to get it into your brain that it’s available.”
Explore the cutting edge of skin cancer detection technology through our latest press releases. Stay ahead in the realm of healthcare innovation and dive into the most recent updates from DermaSensor.
Meet DermaSensor in person and get a live demo
February 19, 2026
- February 21, 2026
February 22, 2026
- February 25, 2026
April 16, 2026
- April 18, 2026
The device Instructions For Use (IFU) is included with each device and provides all guidance and information that users need for device operation, including detailed information on the several clinical studies submitted to the FDA.
Never miss important updates. Subscribe to receive news, events,
and documents straight to your inbox.